Ignite Creation Date:
2025-12-25 @ 2:11 AM
Ignite Modification Date:
2026-04-13 @ 5:55 PM
Study NCT ID:
NCT00502060
Status:
COMPLETED
Last Update Posted:
2009-05-14
First Post:
2007-07-13
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase I Study of AZD2171 co-Administered With Fixed Multiple Oral Doses of ZD1839 in Patients With Advanced Cancer
Sponsor:
AstraZeneca
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2004-08
Start Date Type:
None
Primary Completion Date:
2006-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2006-06
Completion Date Type:
ACTUAL
First Submit Date:
2007-07-13
First Submit QC Date:
None
Study First Post Date:
2007-07-17
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2009-05-13
Last Update Post Date:
2009-05-14
Last Update Post Date Type:
ESTIMATED